Medication Price Control Act of 1991

Summary

Medication Price Control Act of 1990 - Amends the Internal Revenue Code to disallow the credit for increasing research activities for any drug which is determined by the Food and Drug Administration to essentially duplicate in medical importance and therapeutic usage one or more already marketed drugs. Requires any taxpayer that claimed such a credit to notify the Secretary of the Treasury of such a determination through an information return. Disallows such research credit for taxpayers who charge an excessive price for any new therapeutic medication manufactured by the taxpayer.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 November 1991

   Introduced

   Referred to the House Committee on Ways and Means.

   Source: IntroReferral

2. 19 November 1991

   Introduced

   Introduced in House

   Source: IntroReferral

3. 19 November 1991

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · undated · Official file

Documents

2 official files

• Introduced in House (text)

  Introduced in House · EN

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 19 November 1991

  Open at official source

Sponsors

• Rep. Stark, Fortney Pete [D-CA-9] · D · Sponsor
• · hswm00 · Standing

Related records

No cross-record relationships stored yet.